Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India
- PMID: 35324007
- PMCID: PMC9087646
- DOI: 10.1002/ijgo.14189
Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India
Abstract
Objective: Data on the immune response to SARS-CoV-2 during pregnancy are lacking and the potential role and effect of SARS-CoV-2 vaccination in pregnancy is yet to be completely investigated.
Method: This is a cross-sectional observational study wherein pregnant women were tested for SARS-CoV-2 immunoglobulin M and immunoglobulin G levels, irrespective of their infective status or presence or symptomatology.
Result: Of the 220 pregnant women tested, 160 (72.7%) were SARS-CoV-2 IgG positive, 37 (16.8%) were SARS-CoV-2 IgM positive and 27 (16.9%) were both IgG and IgM positive. The average antibody titer found was 10.49 BAU/ml (±14.0) and 0.6 (±0.55) for anti-SARS-CoV-2 IgG and IgM non neutralizing antibodies respectively. ROC analysis for SARS-CoV-2 IgG positivity showed a cut-off value of 1.19 with a sensitivity of 99.3% (0.99 AUC, 95% CI) and specificity of 98.3% (0.99 AUC, 95% CI), respectively. Similarly, ROC analysis for SARS-CoV-2 IgM positivity showed a cut-off value of 1 with a sensitivity of 97.3% (0.99 AUC, 95% CI) and specificity of 98.9% (0.99 AUC, 95% CI), respectively.
Conclusion: First trimester sero-molecular screening suggests a high prevalence of COVID antibodies in the study population of pregnant women in the first trimester, without the patients being symptomatic.
Keywords: COVID; SARS-CoV-2; first trimester; pandemic; pregnancy; seroprevalence; wave.
© 2022 International Federation of Gynecology and Obstetrics.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Comment in
-
Letter to the Editor: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.Int J Gynaecol Obstet. 2022 Aug;158(2):494. doi: 10.1002/ijgo.14289. Epub 2022 Jun 14. Int J Gynaecol Obstet. 2022. PMID: 35698856 Free PMC article. No abstract available.
References
-
- Johns Hopkins Coronavirus Resource Center . Jhu.edu. [cited 2021 Oct 11]. Available from: https://coronavirus.jhu.edu/map.html.
-
- RCOG Guidelines on coronavirus (COVID) infection in pregnancy. https://www.rcog.org.uk/globalassets/documents/guidelines/2021‐08‐25‐cor....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
